Coronavirus
To visit the Select Subcommittee on the Coronavirus Crisis, click here.
In light of the ongoing Coronavirus crisis, the Committee on Oversight and Reform has been conducting oversight of our nation's preparedness for, and response to, the outbreak. The Committee's top priority is promoting the health and safety of the American people, and the information below is from the Committee's investigative activities, the Centers for Disease Control and Prevention (CDC), and other sources.
Oversight Committee Hearing Mentioned on NBC's Meet the Press, March 15, 2020:
Full Committee Activities:
More on Coronavirus
Washington D.C. (February 25, 2022)—On Tuesday, March 1, 2022, at 10 a.m. ET, Rep. Carolyn B.
Washington, D.C. (November 5, 2021)— Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, and Rep. James E.
Washington, D.C. (September 23, 2021)— Today, Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, issued a subpoena to Dr. Steven Hatfill, an advisor to former Director of the White House Office of Trade and Manufacturing Policy Peter Navarro. The subpoena orders Dr.
Washington, D.C. (September 20, 2021) — On Wednesday, September 22, 2021 at 2:00 p.m., Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, will hold a hybrid remote/in-person hearing on pandemic relief programs. The hearing will examine outcomes of these measures and identify further action needed to build a strong, sustainable, and inclusive post-pandemic economy.
Washington, D.C. (September 15, 2021) — Today, the Members of the Select Subcommittee on the Coronavirus Crisis, chaired by Rep. James E. Clyburn, were briefed on the status of the coronavirus vaccine landscape in the United States by Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research at the Food and Drug Administration (FDA).
Chairman Clyburn said in opening the briefing: